You are not too old for menopause treatment

A single birthday should not erase your options for menopause care, yet many women hear a flat “no” the moment they turn 65. We challenge that reflex with evidence, clinical nuance, and practical guidance on how hormone therapy after age 65 can still fit into real life, especially when symptoms, bone health, and genitourinary syndrome of menopause are still in the picture. We walk through a blockbuster Medicare claims analysis of 10.9 million U.S. women over 65 tracked from 2007 to 2020, looking at outcomes tied to different hormone therapy types, doses, and routes: vaginal estrogen, transdermal estrogen patches, and oral estrogen. Then we get practical. We talk estrogen patch shortages, progesterone supply problems, and how pharmacy pricing and formularies can block care. We also cover why “hormonal age” of menopause matters, when labs like FSH and estradiol help, and how common supplements like biotin can interfere with testing. If you’ve been told it’s “too late,” listen and bring your questions. Subscribe, share this with a friend, and leave a review so more women can find evidence-based menopause care.